Chinova Bioworks uses a natural and effective antimicrobial chitosan polymer with broad spectrum protection.
Chinova Bioworks has raised $6.0M in total funding. The most recent round was Series A. The last funding was announced in June 2022.
Chinova Bioworks's investors include Creative Destruction Lab, SOSV, AgFunder, Rhapsody Venture Partners, New Brunswick Innovation Foundation.
Chinova Bioworks is headquartered in Fredericton, Canada.
Chinova Bioworks uses a natural and effective antimicrobial chitosan polymer with broad spectrum protection.
Chinova Bioworks is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Chinova Bioworks — Funding & Investors." VCBacked, June 22, 2022, https://www.vcbacked.co/company/chinova-bioworks. Accessed August 14, 2026.
VCBacked. (2022). Chinova Bioworks — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/chinova-bioworks
{{cite web |title=Chinova Bioworks — Funding & Investors |url=https://www.vcbacked.co/company/chinova-bioworks |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated